Odysseas Kostas

Odysseas Kostas is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as a Member of the Board of Directors at Amarin Corporation, Armata Pharmaceuticals, and Innoviva while holding the position of Senior Managing Director at Sarissa Capital Management LP since January 2016. Kostas has a strong foundation in healthcare equity research, having worked as an Associate/Director at ISI Group and consulted at Sanford C. Bernstein. Previous experience includes serving as Director at Enzon Pharmaceuticals and ADVENTRX Pharmaceuticals, as well as hospitalist duties at Greenwich Hospital. Kostas founded a successful internal medicine practice, Odysseas D Kostas, MD, LLC, before pursuing a career in consultancy for the biotech and pharmaceutical industries. Educational qualifications include an M.D. from The University of Texas Southwestern Medical School and a B.S. in Biology from the Massachusetts Institute of Technology.